Project Details
Description
A randomized, open label, multicenter study of a belatacept-based early glucocorticoid withdrawal regimen with alemtuzumab
| Status | Finished |
|---|---|
| Effective start/end date | 2/28/12 → 6/30/19 |
Funding
- UNIVERSITY OF CINCINNATI
- BRISTOL-MYERS SQUIBB COMPANY
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.